The LDL-c challenge in high cardiovascular risk - Integrating innovative therapies in clinical management - PACE-CME

Episodes 1-5 of 5

The evolving need and challenges to reach LDL-c targets in high-risk patients
The evolving need and challenges to reach LDL-c targets in high-risk patients
MinuteCE®
The evolving need and challenges to reach LDL-c targets in high-risk patients
1.00 program credit
- Kausik Ray, MBChB, MD, MPhil
1.00 program credit
PCSK9i: Benefits across the spectrum of cardiovascular disease
PCSK9i: Benefits across the spectrum of cardiovascular disease
MinuteCE®
PCSK9i: Benefits across the spectrum of cardiovascular disease
1.00 program credit
- Fabrice Martens
1.00 program credit
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
MinuteCE®
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
1.00 program credit
- Erin Michos
1.00 program credit
Oral cholesterol-lowering therapies: The basis of prevention
Oral cholesterol-lowering therapies: The basis of prevention
MinuteCE®
Oral cholesterol-lowering therapies: The basis of prevention
1.00 program credit
- Lale Tokgözoğlu, MD
1.00 program credit
MinuteCE®
The LDL-c challenge in high cardiovascular risk - Integrating innovative therapies in clinical management
1.00 credit 4 episodes
- Kausik Ray, MBChB, MD, MPhil
- Lale Tokgözoğlu, MD
- Fabrice Martens
- Erin Michos
1.00 credit 4 episodes